A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy. (Q38726990)
Jump to navigation
Jump to search
scientific article published on 08 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy. |
scientific article published on 08 February 2016 |
Statements
A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy (English)
Brian Leyland-Jones
Gia Nemsadze
Vitaliy Smirnov
Iryna Litvin
Irakli Kokhreidze
Lia Abshilava
Mikheil Janjalia
Rubi Li
Kuntegowda C Lakshmaiah
Beka Samkharadze
Oksana Tarasova
Ranjan Kumar Mohapatra
Yaroslav Sparyk
Sergey Polenkov
Vladimir Vladimirov
Liang Xiu
Eugene Zhu
Bruce Kimelblatt
Kris Deprince
Ilya Safonov
Peter Bowers